Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
Traumatic brain injury causes $6.8 billion worth of economic trauma in Texas

Traumatic brain injury causes $6.8 billion worth of economic trauma in Texas

Researchers recommend traumatic brain injury reclassification for additional funding

Researchers recommend traumatic brain injury reclassification for additional funding

BrainScope technology specifically identifies triage for Computed Tomography to ED patients

BrainScope technology specifically identifies triage for Computed Tomography to ED patients

Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury

Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury

Sledding-related injuries may result in traumatic brain injury: Study

Sledding-related injuries may result in traumatic brain injury: Study

Back seat drivers right to feel uneasy

Back seat drivers right to feel uneasy

CDC study finds American traumatic brain injury population on the rise

CDC study finds American traumatic brain injury population on the rise

First pathological evidence of link between repeated head injuries and chronic traumatic Encephalomyopathy

First pathological evidence of link between repeated head injuries and chronic traumatic Encephalomyopathy

USPTO to issue reexamination certificate for Neuralstem's patent for neural stem cell technology

USPTO to issue reexamination certificate for Neuralstem's patent for neural stem cell technology

Study finds disparities in evaluation, diagnosis of abuse among infants with traumatic brain injury

Study finds disparities in evaluation, diagnosis of abuse among infants with traumatic brain injury

Brain trauma in sports associated with motor neuron disease, researchers find

Brain trauma in sports associated with motor neuron disease, researchers find

Simple measure saves children’s lives: study

Simple measure saves children’s lives: study

Bicycle helmet laws need review: Health expert

Bicycle helmet laws need review: Health expert

DynaVox releases software Version 2.0 for Xpress communication device

DynaVox releases software Version 2.0 for Xpress communication device

Oxygen Biotherapeutics collaborates with U.S. Navy to develop treatment for DCS

Oxygen Biotherapeutics collaborates with U.S. Navy to develop treatment for DCS

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

New study on treating CP with HBOT is making waves in India, U.S.

New study on treating CP with HBOT is making waves in India, U.S.

Research on method to open blood-brain barrier for safe cancer drug delivery

Research on method to open blood-brain barrier for safe cancer drug delivery

First patient enrolled in Phase 3 SyNAPSe study of BHR-100 for TBI

First patient enrolled in Phase 3 SyNAPSe study of BHR-100 for TBI

SDIX announces multi-year collaboration with Banyan Biomarkers

SDIX announces multi-year collaboration with Banyan Biomarkers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.